nodes	percent_of_prediction	percent_of_DWPC	metapath
Metoprolol—ADRB2—autistic disorder	0.857	1	CbGaD
Metoprolol—Chlorphenesin—XDH—autistic disorder	0.00189	0.146	CrCbGaD
Metoprolol—Metipranolol—ADRB2—autistic disorder	0.00106	0.0822	CrCbGaD
Metoprolol—Sotalol—ADRB2—autistic disorder	0.000945	0.0733	CrCbGaD
Metoprolol—Chlorphenesin—CYP19A1—autistic disorder	0.000857	0.0664	CrCbGaD
Metoprolol—Esmolol—ADRB2—autistic disorder	0.000843	0.0653	CrCbGaD
Metoprolol—Bevantolol—ADRB2—autistic disorder	0.000832	0.0645	CrCbGaD
Metoprolol—Betaxolol—ADRB2—autistic disorder	0.000742	0.0575	CrCbGaD
Metoprolol—Atenolol—ADRB2—autistic disorder	0.000735	0.057	CrCbGaD
Metoprolol—Bisoprolol—ADRB2—autistic disorder	0.000716	0.0555	CrCbGaD
Metoprolol—Pindolol—HTR1B—autistic disorder	0.000712	0.0552	CrCbGaD
Metoprolol—Acebutolol—ADRB2—autistic disorder	0.000679	0.0526	CrCbGaD
Metoprolol—Oxprenolol—ADRB2—autistic disorder	0.000674	0.0522	CrCbGaD
Metoprolol—Alprenolol—ADRB2—autistic disorder	0.000616	0.0478	CrCbGaD
Metoprolol—Pindolol—ADRB2—autistic disorder	0.00053	0.0411	CrCbGaD
Metoprolol—Chlorphenesin—PTGS2—autistic disorder	0.000394	0.0305	CrCbGaD
Metoprolol—Propranolol—HTR1B—autistic disorder	0.000389	0.0301	CrCbGaD
Metoprolol—Propranolol—ADRB2—autistic disorder	0.000289	0.0224	CrCbGaD
Metoprolol—ABCB1—Metabolism—DAO—autistic disorder	5.11e-05	0.000394	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—PDE4A—autistic disorder	5.1e-05	0.000394	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—EXT1—autistic disorder	5.05e-05	0.000389	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—SLC6A8—autistic disorder	5.05e-05	0.000389	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—UPB1—autistic disorder	5.02e-05	0.000387	CbGpPWpGaD
Metoprolol—ADRB1—GPCR downstream signaling—ADRB2—autistic disorder	4.92e-05	0.000379	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—UPB1—autistic disorder	4.9e-05	0.000378	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—AVPR1A—autistic disorder	4.89e-05	0.000377	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—DAO—autistic disorder	4.81e-05	0.000371	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—TPH2—autistic disorder	4.79e-05	0.000369	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—AVPR1A—autistic disorder	4.78e-05	0.000369	CbGpPWpGaD
Metoprolol—ABCB1—Transmembrane transport of small molecules—TF—autistic disorder	4.75e-05	0.000366	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—VIP—autistic disorder	4.72e-05	0.000364	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—GRM5—autistic disorder	4.72e-05	0.000364	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—DPYD—autistic disorder	4.71e-05	0.000363	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—GSTM5—autistic disorder	4.66e-05	0.00036	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—ASMT—autistic disorder	4.66e-05	0.00036	CbGpPWpGaD
Metoprolol—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—autistic disorder	4.62e-05	0.000357	CbGpPWpGaD
Metoprolol—ADRB1—GPCR downstream signaling—AVP—autistic disorder	4.62e-05	0.000356	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—GRM5—autistic disorder	4.62e-05	0.000356	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—VIP—autistic disorder	4.62e-05	0.000356	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—UPB1—autistic disorder	4.61e-05	0.000356	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—OXTR—autistic disorder	4.57e-05	0.000352	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—GSTM5—autistic disorder	4.55e-05	0.000351	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—ASMT—autistic disorder	4.55e-05	0.000351	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—SCT—autistic disorder	4.52e-05	0.000349	CbGpPWpGaD
Metoprolol—ADRB2—GPCR downstream signaling—AVP—autistic disorder	4.52e-05	0.000349	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—OXTR—autistic disorder	4.47e-05	0.000345	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—ADRB2—autistic disorder	4.47e-05	0.000344	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—SCT—autistic disorder	4.43e-05	0.000341	CbGpPWpGaD
Metoprolol—SLC22A2—Transmission across Chemical Synapses—HRAS—autistic disorder	4.41e-05	0.00034	CbGpPWpGaD
Metoprolol—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—autistic disorder	4.39e-05	0.000339	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—SLC25A12—autistic disorder	4.39e-05	0.000338	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—CACNA1C—autistic disorder	4.38e-05	0.000338	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—GABBR1—autistic disorder	4.32e-05	0.000333	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—ADM—autistic disorder	4.32e-05	0.000333	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—GSTM5—autistic disorder	4.29e-05	0.000331	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—ASMT—autistic disorder	4.29e-05	0.000331	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—SLC25A12—autistic disorder	4.28e-05	0.00033	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—SLC19A1—autistic disorder	4.27e-05	0.000329	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—EIF4E—autistic disorder	4.24e-05	0.000327	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—ADM—autistic disorder	4.22e-05	0.000326	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—GABBR1—autistic disorder	4.22e-05	0.000326	CbGpPWpGaD
Metoprolol—SLC22A2—Neuronal System—MAPK1—autistic disorder	4.21e-05	0.000325	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—PDE4B—autistic disorder	4.21e-05	0.000324	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—AVP—autistic disorder	4.2e-05	0.000324	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—SLC19A1—autistic disorder	4.16e-05	0.000321	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—EIF4E—autistic disorder	4.15e-05	0.00032	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—PDE4B—autistic disorder	4.11e-05	0.000317	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—AVP—autistic disorder	4.1e-05	0.000316	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—OPRM1—autistic disorder	4.07e-05	0.000314	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—SLC25A12—autistic disorder	4.03e-05	0.000311	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—OPRM1—autistic disorder	3.98e-05	0.000307	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—DHFR—autistic disorder	3.98e-05	0.000307	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—PLA2G4A—autistic disorder	3.95e-05	0.000304	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—SLC19A1—autistic disorder	3.92e-05	0.000303	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—autistic disorder	3.92e-05	0.000302	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—PLA2G4A—autistic disorder	3.86e-05	0.000298	CbGpPWpGaD
Metoprolol—ADRB1—GPCR downstream signaling—HTR2A—autistic disorder	3.85e-05	0.000296	CbGpPWpGaD
Metoprolol—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—autistic disorder	3.83e-05	0.000295	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—ADSL—autistic disorder	3.8e-05	0.000293	CbGpPWpGaD
Metoprolol—ADRB2—GPCR downstream signaling—HTR2A—autistic disorder	3.76e-05	0.00029	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—XDH—autistic disorder	3.73e-05	0.000288	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—GZMB—autistic disorder	3.73e-05	0.000287	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—ADSL—autistic disorder	3.71e-05	0.000286	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—STX1A—autistic disorder	3.66e-05	0.000282	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—NPAS2—autistic disorder	3.66e-05	0.000282	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—GZMB—autistic disorder	3.64e-05	0.000281	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—XDH—autistic disorder	3.64e-05	0.000281	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—OXT—autistic disorder	3.62e-05	0.000279	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—HTR1B—autistic disorder	3.62e-05	0.000279	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—STX1A—autistic disorder	3.57e-05	0.000275	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—NPAS2—autistic disorder	3.57e-05	0.000275	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—OXT—autistic disorder	3.54e-05	0.000273	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—HTR1B—autistic disorder	3.54e-05	0.000273	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—TCN2—autistic disorder	3.54e-05	0.000273	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—ADSL—autistic disorder	3.5e-05	0.00027	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—HTR2A—autistic disorder	3.49e-05	0.000269	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—TCN2—autistic disorder	3.45e-05	0.000266	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—XDH—autistic disorder	3.43e-05	0.000264	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—HTR2A—autistic disorder	3.42e-05	0.000263	CbGpPWpGaD
Metoprolol—SLC22A2—Neuronal System—HRAS—autistic disorder	3.38e-05	0.000261	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—ADA—autistic disorder	3.37e-05	0.00026	CbGpPWpGaD
Metoprolol—ADRB1—GPCR downstream signaling—PRKCB—autistic disorder	3.37e-05	0.00026	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—STX1A—autistic disorder	3.37e-05	0.00026	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—NPAS2—autistic disorder	3.37e-05	0.00026	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—TSC1—autistic disorder	3.36e-05	0.000259	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—DRD1—autistic disorder	3.36e-05	0.000259	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G4A—autistic disorder	3.33e-05	0.000257	CbGpPWpGaD
Metoprolol—ADRB2—GPCR downstream signaling—PRKCB—autistic disorder	3.3e-05	0.000254	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—ADA—autistic disorder	3.29e-05	0.000254	CbGpPWpGaD
Metoprolol—ABCB1—Transmembrane transport of small molecules—AVP—autistic disorder	3.29e-05	0.000254	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—TSC1—autistic disorder	3.29e-05	0.000254	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—DRD1—autistic disorder	3.29e-05	0.000254	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—NTRK2—autistic disorder	3.27e-05	0.000252	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—DRD3—autistic disorder	3.26e-05	0.000251	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—TCN2—autistic disorder	3.25e-05	0.000251	CbGpPWpGaD
Metoprolol—ADRB1—GPCR downstream signaling—PIK3CG—autistic disorder	3.23e-05	0.000249	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—NTRK2—autistic disorder	3.2e-05	0.000247	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—autistic disorder	3.19e-05	0.000246	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—IL5—autistic disorder	3.19e-05	0.000246	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—DRD3—autistic disorder	3.19e-05	0.000246	CbGpPWpGaD
Metoprolol—ADRB2—GPCR downstream signaling—PIK3CG—autistic disorder	3.16e-05	0.000243	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—CALCA—autistic disorder	3.15e-05	0.000243	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—CYP19A1—autistic disorder	3.12e-05	0.000241	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—IL5—autistic disorder	3.12e-05	0.00024	CbGpPWpGaD
Metoprolol—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—autistic disorder	3.11e-05	0.00024	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—ADA—autistic disorder	3.1e-05	0.000239	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—CALCA—autistic disorder	3.08e-05	0.000237	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—RORA—autistic disorder	3.08e-05	0.000237	CbGpPWpGaD
Metoprolol—ADRB1—GPCR downstream signaling—POMC—autistic disorder	3.07e-05	0.000237	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—PRKCB—autistic disorder	3.06e-05	0.000236	CbGpPWpGaD
Metoprolol—ADRB2—GPCR downstream signaling—POMC—autistic disorder	3e-05	0.000232	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—RORA—autistic disorder	3e-05	0.000231	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—PRKCB—autistic disorder	2.99e-05	0.000231	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—PIK3CG—autistic disorder	2.93e-05	0.000226	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—COMT—autistic disorder	2.9e-05	0.000224	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—GSTP1—autistic disorder	2.89e-05	0.000223	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—MAOB—autistic disorder	2.88e-05	0.000222	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—MAOA—autistic disorder	2.88e-05	0.000222	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—PIK3CG—autistic disorder	2.87e-05	0.000221	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—RORA—autistic disorder	2.83e-05	0.000218	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—MAOB—autistic disorder	2.81e-05	0.000217	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—CAT—autistic disorder	2.81e-05	0.000217	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—POMC—autistic disorder	2.79e-05	0.000215	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—PRL—autistic disorder	2.78e-05	0.000214	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism of lipids and lipoproteins—APOE—autistic disorder	2.74e-05	0.000211	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—POMC—autistic disorder	2.73e-05	0.00021	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—PRL—autistic disorder	2.72e-05	0.00021	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—TPH2—autistic disorder	2.68e-05	0.000207	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—PLA2G4A—autistic disorder	2.65e-05	0.000204	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—GSTM1—autistic disorder	2.65e-05	0.000204	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—MAOB—autistic disorder	2.65e-05	0.000204	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—ADRB2—autistic disorder	2.64e-05	0.000203	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—DPYD—autistic disorder	2.64e-05	0.000203	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—TPH2—autistic disorder	2.61e-05	0.000202	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—DPYD—autistic disorder	2.57e-05	0.000198	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—GPX1—autistic disorder	2.54e-05	0.000196	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—AVP—autistic disorder	2.48e-05	0.000191	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—autistic disorder	2.48e-05	0.000191	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—IGF2—autistic disorder	2.47e-05	0.00019	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—TPH2—autistic disorder	2.46e-05	0.00019	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—CACNA1C—autistic disorder	2.45e-05	0.000189	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—AVP—autistic disorder	2.42e-05	0.000187	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—DPYD—autistic disorder	2.42e-05	0.000187	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—IGF2—autistic disorder	2.41e-05	0.000186	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—CACNA1C—autistic disorder	2.39e-05	0.000184	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism of lipids and lipoproteins—POMC—autistic disorder	2.36e-05	0.000182	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—MTHFR—autistic disorder	2.34e-05	0.000181	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—PLA2G4A—autistic disorder	2.33e-05	0.00018	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—PLA2G4A—autistic disorder	2.28e-05	0.000176	CbGpPWpGaD
Metoprolol—ADRB1—GPCR downstream signaling—IL2—autistic disorder	2.27e-05	0.000175	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—MEF2C—autistic disorder	2.27e-05	0.000175	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—CACNA1C—autistic disorder	2.25e-05	0.000174	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—DHFR—autistic disorder	2.23e-05	0.000172	CbGpPWpGaD
Metoprolol—ADRB2—GPCR downstream signaling—IL2—autistic disorder	2.22e-05	0.000171	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—MEF2C—autistic disorder	2.22e-05	0.000171	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—ITGB3—autistic disorder	2.21e-05	0.00017	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—APOE—autistic disorder	2.18e-05	0.000168	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—DHFR—autistic disorder	2.18e-05	0.000168	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—ITGB3—autistic disorder	2.16e-05	0.000167	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—HTR2A—autistic disorder	2.06e-05	0.000159	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—IL2—autistic disorder	2.06e-05	0.000159	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—DHFR—autistic disorder	2.05e-05	0.000158	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—HTR2A—autistic disorder	2.02e-05	0.000156	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—IL2—autistic disorder	2.02e-05	0.000155	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—PIK3CG—autistic disorder	1.97e-05	0.000152	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—TSC2—autistic disorder	1.96e-05	0.000151	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—APOE—autistic disorder	1.92e-05	0.000148	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—LEP—autistic disorder	1.92e-05	0.000148	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—TSC2—autistic disorder	1.92e-05	0.000148	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—autistic disorder	1.88e-05	0.000145	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—APOE—autistic disorder	1.88e-05	0.000145	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—LEP—autistic disorder	1.88e-05	0.000145	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—POMC—autistic disorder	1.87e-05	0.000145	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—PRKCB—autistic disorder	1.81e-05	0.000139	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—PRKCB—autistic disorder	1.77e-05	0.000136	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—CYP19A1—autistic disorder	1.75e-05	0.000135	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—APC—autistic disorder	1.73e-05	0.000133	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—PIK3CG—autistic disorder	1.73e-05	0.000133	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—EGF—autistic disorder	1.71e-05	0.000132	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—CYP19A1—autistic disorder	1.7e-05	0.000131	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—APC—autistic disorder	1.69e-05	0.000131	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—PIK3CG—autistic disorder	1.69e-05	0.000131	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—EGF—autistic disorder	1.67e-05	0.000129	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—POMC—autistic disorder	1.65e-05	0.000127	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—autistic disorder	1.64e-05	0.000126	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—COMT—autistic disorder	1.62e-05	0.000125	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—GSTP1—autistic disorder	1.62e-05	0.000125	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—MAOA—autistic disorder	1.61e-05	0.000124	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—POMC—autistic disorder	1.61e-05	0.000124	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—CYP19A1—autistic disorder	1.61e-05	0.000124	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—IGF1—autistic disorder	1.58e-05	0.000122	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—COMT—autistic disorder	1.58e-05	0.000122	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—MAPK1—autistic disorder	1.58e-05	0.000122	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—GSTP1—autistic disorder	1.58e-05	0.000122	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—MAOA—autistic disorder	1.57e-05	0.000121	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—CAT—autistic disorder	1.57e-05	0.000121	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—IGF1—autistic disorder	1.55e-05	0.00012	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—MAPK1—autistic disorder	1.54e-05	0.000119	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—CAT—autistic disorder	1.53e-05	0.000118	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—SERPINE1—autistic disorder	1.5e-05	0.000116	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—PTGS2—autistic disorder	1.5e-05	0.000115	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—COMT—autistic disorder	1.49e-05	0.000115	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—GSTP1—autistic disorder	1.49e-05	0.000115	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—PLA2G4A—autistic disorder	1.48e-05	0.000114	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—GSTM1—autistic disorder	1.48e-05	0.000114	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—MAOA—autistic disorder	1.48e-05	0.000114	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—SERPINE1—autistic disorder	1.47e-05	0.000113	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—PLA2G4A—autistic disorder	1.45e-05	0.000112	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—GSTM1—autistic disorder	1.45e-05	0.000112	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—CAT—autistic disorder	1.45e-05	0.000111	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—GPX1—autistic disorder	1.42e-05	0.00011	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—GPX1—autistic disorder	1.39e-05	0.000107	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—PLA2G4A—autistic disorder	1.37e-05	0.000105	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—GSTM1—autistic disorder	1.37e-05	0.000105	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—MTHFR—autistic disorder	1.31e-05	0.000101	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—GPX1—autistic disorder	1.31e-05	0.000101	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—PTEN—autistic disorder	1.3e-05	0.000101	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—MTHFR—autistic disorder	1.28e-05	9.87e-05	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—HRAS—autistic disorder	1.27e-05	9.76e-05	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—HRAS—autistic disorder	1.24e-05	9.55e-05	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—APOE—autistic disorder	1.22e-05	9.42e-05	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—IL2—autistic disorder	1.22e-05	9.39e-05	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—IL6—autistic disorder	1.21e-05	9.34e-05	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—MTHFR—autistic disorder	1.21e-05	9.3e-05	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—APOE—autistic disorder	1.19e-05	9.19e-05	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—IL2—autistic disorder	1.19e-05	9.19e-05	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—IL6—autistic disorder	1.19e-05	9.14e-05	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—PTEN—autistic disorder	1.15e-05	8.83e-05	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—APOE—autistic disorder	1.12e-05	8.66e-05	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—PTEN—autistic disorder	1.12e-05	8.64e-05	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—PIK3CG—autistic disorder	1.1e-05	8.5e-05	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—PIK3CG—autistic disorder	1.08e-05	8.3e-05	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—POMC—autistic disorder	1.05e-05	8.09e-05	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—POMC—autistic disorder	1.02e-05	7.9e-05	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—PIK3CG—autistic disorder	1.01e-05	7.82e-05	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—POMC—autistic disorder	9.65e-06	7.44e-05	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—MAPK1—autistic disorder	9.32e-06	7.18e-05	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—MAPK1—autistic disorder	9.11e-06	7.03e-05	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—PTGS2—autistic disorder	8.37e-06	6.45e-05	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—PTGS2—autistic disorder	8.17e-06	6.3e-05	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—PTGS2—autistic disorder	7.7e-06	5.94e-05	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—HRAS—autistic disorder	7.48e-06	5.77e-05	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—HRAS—autistic disorder	7.32e-06	5.64e-05	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—PTEN—autistic disorder	7.3e-06	5.63e-05	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—IL6—autistic disorder	7.16e-06	5.52e-05	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—PTEN—autistic disorder	7.12e-06	5.49e-05	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—IL6—autistic disorder	7e-06	5.4e-05	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—PTEN—autistic disorder	6.71e-06	5.18e-05	CbGpPWpGaD
